HH
EBS icon

Hilltop Holdings’s Emergent Biosolutions EBS Stock Holding History

Hilltop Holdings’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60,861
Closed -$537K – 920
2025
Q3 		$537K Sell
60,861
-100
-0.2% -$778 0.03% 547
2025
Q2 		$389K Buy
60,961
+1,200
+2% +$6.87K 0.02% 597
2025
Q1 		$290K Sell
59,761
-94,614
-61% -$783K 0.02% 683
2024
Q4 		$1.48M Sell
154,375
-16,891
-10% -$155K 0.09% 232
2024
Q3 		$1.43M Buy
171,266
+12,515
+8% +$114K 0.09% 238
2024
Q2 		$1.08M Sell
158,751
-47,948
-23% -$206K 0.13% 210
2024
Q1 		$523K Sell
206,699
-5,470
-3% -$12.3K 0.05% 367
2023
Q4 		$509K Sell
212,169
-22,850
-10% -$53.7K 0.06% 354
2023
Q3 		$799K Buy
+235,019
New +$1.3M 0.09% 253

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hilltop Holdings's EBS Position: Q4 2025 in Review

Hilltop Holdings sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 60,861 shares — an estimated $537K sold.

Hilltop Holdings first reported a position in EBS in Q3 2023 and held it in 9 quarters. The position peaked at $1.48M in Q4 2024. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • Hilltop Holdings reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • Hilltop Holdings sold 60,861 Emergent Biosolutions shares in Q4 2025, an estimated $537K.
  • Hilltop Holdings first reported a position in Emergent Biosolutions in Q3 2023 and held it in 9 quarters.
  • Hilltop Holdings's Emergent Biosolutions position peaked at $1.48M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Hilltop Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.